{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:40:24Z","timestamp":1777480824103,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.iac.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T21:27:33Z","timestamp":1528579653000},"page":"455-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder"],"prefix":"10.1016","volume":"38","author":[{"given":"Patrizia","family":"Bonadonna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Scaffidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2018.04.010_bib1","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"54","year":"2008"},{"key":"10.1016\/j.iac.2018.04.010_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.iac.2018.04.010_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib4","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological and molecular characteristics of systemic mast cell disorders presenting with severe mediator-related symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","article-title":"Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group","volume":"97","author":"Lieberman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2018.04.010_bib7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish Network on Mastocytosis (REMA)","volume":"37","author":"Gonz\u00e1lez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis: a single-centre experience","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2018.04.010_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11882-015-0582-5","article-title":"Hymenoptera allergy and mast cell activation syndromes","volume":"16","author":"Bonadonna","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2018.04.010_bib11","first-page":"331","article-title":"Diagnosis and treatment of insect sensitivity","volume":"3","author":"Mueller","year":"1966","journal-title":"J\u00a0Asthma Res"},{"issue":"7","key":"10.1016\/j.iac.2018.04.010_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1398-9995.2006.01077.x","article-title":"European polistes venom allergy","volume":"61","author":"Severino","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib13","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1398-9995.2005.00960.x","article-title":"Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice","volume":"60","author":"Bonifazi","year":"2005","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2018.04.010_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.all.0000136756.20701.f8","article-title":"Mastocytosis and Hymenoptera allergy","volume":"4","author":"Dubois","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","article-title":"Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy","volume":"33","author":"Haeberli","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.all.0000235903.10548.63","article-title":"Mastocytosis and Hymenoptera venom allergy","volume":"6","author":"Rueff","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2222.2009.03210.x","article-title":"Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase","volume":"39","author":"Potier","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.iac.2018.04.010_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2009.02302.x","article-title":"Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly","volume":"65","author":"Guenova","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1046\/j.1365-2133.1999.03214.x","article-title":"Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels","volume":"141","author":"Biedermann","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2018.04.010_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0091-6749(83)90630-9","article-title":"Anaphylaxis after Hymenoptera stings in three patients with urticaria pigmentosa","volume":"72","author":"M\u00fcller","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.04.010_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000083954","article-title":"Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes","volume":"136","author":"Florian","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)70314-2","article-title":"Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis","volume":"99","author":"Oude Elberink","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.iac.2018.04.010_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaci.2009.02.003","article-title":"Assessing anaphylactic risk? Consider mast cell clonality","volume":"123","author":"Metcalfe","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1398-9995.2012.02809.x","article-title":"Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions","volume":"67","author":"Van Doormaal","year":"2012","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2018.04.010_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2014.11.035","article-title":"Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels","volume":"136","author":"Zanotti","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaci.2012.10.052","article-title":"Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis","volume":"13","author":"Alvarez-Twose","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.04.010_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","article-title":"Bone involvement and osteoporosis in mastocytosis","volume":"34","author":"Rossini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"suppl 144","key":"10.1016\/j.iac.2018.04.010_bib30","first-page":"S14","article-title":"Fatal outcome of a Vespula sting in a patient with mastocytosis after specific immunotherapy with honey bee venom","volume":"135","author":"Reimers","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.iac.2018.04.010_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.12.738","article-title":"Anaphylactic reactions after discontinuation of Hymenoptera venom immunotherapy: a clonal mast cell disorder should be suspected","author":"Bonadonna","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9253","key":"10.1016\/j.iac.2018.04.010_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(00)03647-3","article-title":"Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings","volume":"357","author":"Ludolph-Hauser","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2018.04.010_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(97)70188-X","article-title":"Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients","volume":"100","author":"Fricker","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Non aggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.04.010_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaip.2015.03.015","article-title":"Anaphylaxis after Hymenoptera sting: is it venom allergy, a clonal disorder, or both?","volume":"3","author":"Castells","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2018.04.010_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"Van Anrooij","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"157","key":"10.1016\/j.iac.2018.04.010_bib37","first-page":"399","article-title":"Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience","volume":"25","author":"Wimazal","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib38","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1398-9995.2005.00963.x","article-title":"Diagnosis of Hymenoptera venom allergy","volume":"60","author":"Bil\u00f2","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1398-9995.1996.tb00144.x","article-title":"IgE antibodies to Hymenoptera venoms in the serum are common in the general population and are related to indications of atopy","volume":"51","author":"Schafer","year":"1996","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000161586","article-title":"Asymptomatic sensitization to Hymenoptera venom is related to total immunoglobulin E levels","volume":"148","author":"Sturm","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib41","doi-asserted-by":"crossref","first-page":"e20842","DOI":"10.1371\/journal.pone.0020842","article-title":"Inconsistent results of diagnostic tools hamper the differentiation between bee and vespid venom allergy","volume":"6","author":"Sturm","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2018.04.010_bib42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1067\/mai.2001.120013","article-title":"Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy","volume":"108","author":"Hemmer","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib43","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jaci.2013.10.046","article-title":"Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare","volume":"133","author":"Sturm","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib44","first-page":"238","article-title":"Insect stings: clinical features and management","volume":"109","author":"Przybilla","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.iac.2018.04.010_bib45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1398-9995.2012.02849.x","article-title":"The role of basophil activation test in special populations with mastocytosis and reactions to Hymenoptera sting","volume":"67","author":"Bonadonna","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaip.2013.06.014","article-title":"Venom Immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations","volume":"1","author":"Bonadonna","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2018.04.010_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/all.12850","article-title":"Added sensitivity of component-resolved diagnosis in Hymenoptera venom-allergic patients with elevated serum tryptase and\/or mastocytosis","volume":"71","author":"Michel","year":"2016","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2018.04.010_bib48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cea.13090","article-title":"Component-resolved diagnostics to direct in venom immunotherapy: important steps towards precision medicine","volume":"48","author":"Blank","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cca.2015.12.026","article-title":"Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies","volume":"453","author":"Caruso","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.iac.2018.04.010_bib50","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaip.2017.03.019","article-title":"Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients","volume":"5","author":"Vos","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2018.04.010_bib51","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.12698","article-title":"The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease","volume":"70","author":"Hoffmann","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib52","first-page":"204","article-title":"Flow cytometric cellular allergen stimulation test (FAST\/Flow- CAST): technical and clinical evaluation of a new diagnostic test in allergy and pseudo-allergy","volume":"14","author":"De Weck","year":"2002","journal-title":"ACI Int"},{"key":"10.1016\/j.iac.2018.04.010_bib53","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1398-9995.2004.00400.x","article-title":"The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study","volume":"59","author":"Sturm","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib54","first-page":"10","article-title":"Use of CD63 expression as marker of in\u00a0vitro basophil activation in identifying the culprit in insect venom allergy","volume":"14","author":"Eberlein-Konig","year":"2004","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ACI.0b013e3282638848","article-title":"Basophil-activation tests in Hymenoptera allergy","volume":"7","author":"Dubois","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.b.20577","article-title":"Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis","volume":"80","author":"Gonzalez-de-Olano","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.iac.2018.04.010_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000444996","article-title":"The basophil activation test is not a useful screening tool for Hymenoptera venom-related anaphylaxis in patients with systemic mastocytosis","volume":"169","author":"Rietveld","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2018.04.010_bib58","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib59","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1398-9995.2009.02118.x","article-title":"Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy","volume":"64","author":"Niedoszykto","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.010_bib60","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1517\/14656566.2011.616494","article-title":"Safety of Hymenoptera venom immunotherapy: a systematic review","volume":"12","author":"Incorvaia","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.iac.2018.04.010_bib61","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0091-6749(94)90213-5","article-title":"Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease","volume":"94","author":"Engler","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.010_bib62","first-page":"225","article-title":"Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab","volume":"19","author":"Galera","year":"2009","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2018.04.010_bib63","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1398-9995.2009.02045.x","article-title":"Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis","volume":"64","author":"Kontou-Fili","year":"2009","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2018.04.010_bib64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaip.2013.07.004","article-title":"Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome","volume":"1","author":"da Silva","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2018.04.010_bib65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaip.2014.03.009","article-title":"Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report","volume":"2","author":"Sokol","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2018.04.010_bib66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2796.1993.tb00984.x","article-title":"Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis","volume":"233","author":"Kors","year":"1993","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.iac.2018.04.010_bib67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anai.2012.09.014","article-title":"Efficacy of venom immunotherapy given every 3 or 4\u00a0months: a prospective comparison with the conventional regimen","volume":"110","author":"Simioni","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.iac.2018.04.010_bib68","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/all.12908","article-title":"Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI task force consensus statement","volume":"71","author":"Bil\u00f2","year":"2016","journal-title":"Allergy"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T11:12:43Z","timestamp":1720350763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856118300389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0889856118300389"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2018.04.010","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}